These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production. Han C; Yu G; Mao Y; Song S; Li L; Zhou L; Wang Z; Liu Y; Li M; Xu B PLoS One; 2020; 15(11):e0240801. PubMed ID: 33137125 [TBL] [Abstract][Full Text] [Related]
4. ROBO4 deletion ameliorates PAF-mediated skin inflammation via regulating the mRNA translation efficiency of LPCAT1/LPCAT2 and the expression of PAF receptor. Xiao X; Zhuang X; Xu C; Chen H; Zhu W; Pang C; Zhang M Int J Biol Sci; 2020; 16(6):1086-1095. PubMed ID: 32140075 [TBL] [Abstract][Full Text] [Related]
5. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis. Saito T; Kasamatsu A; Ogawara K; Miyamoto I; Saito K; Iyoda M; Suzuki T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K PLoS One; 2015; 10(9):e0137923. PubMed ID: 26378920 [TBL] [Abstract][Full Text] [Related]
6. Adenosine A2b receptor promotes progression of human oral cancer. Kasama H; Sakamoto Y; Kasamatsu A; Okamoto A; Koyama T; Minakawa Y; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K BMC Cancer; 2015 Jul; 15():563. PubMed ID: 26228921 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of platelet-activating factor synthases and its receptor in spinal cord contribute to development of neuropathic pain following peripheral nerve injury. Okubo M; Yamanaka H; Kobayashi K; Kanda H; Dai Y; Noguchi K Mol Pain; 2012 Feb; 8():8. PubMed ID: 22296727 [TBL] [Abstract][Full Text] [Related]
8. Dermatopontin: a potential predictor for metastasis of human oral cancer. Yamatoji M; Kasamatsu A; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K Int J Cancer; 2012 Jun; 130(12):2903-11. PubMed ID: 21796630 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma. Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778 [TBL] [Abstract][Full Text] [Related]
11. Protein O-fucosyltransferase 1: a potential diagnostic marker and therapeutic target for human oral cancer. Yokota S; Ogawara K; Kimura R; Shimizu F; Baba T; Minakawa Y; Higo M; Kasamatsu A; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K Int J Oncol; 2013 Dec; 43(6):1864-70. PubMed ID: 24064921 [TBL] [Abstract][Full Text] [Related]
12. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma. Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326 [TBL] [Abstract][Full Text] [Related]
15. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways. Huang Y; Wang Y; Wang Y; Wang N; Duan Q; Wang S; Liu M; Bilal MA; Zheng Y J Invest Dermatol; 2022 Feb; 142(2):303-313.e9. PubMed ID: 34358528 [TBL] [Abstract][Full Text] [Related]
16. ALY as a potential contributor to metastasis in human oral squamous cell carcinoma. Saito Y; Kasamatsu A; Yamamoto A; Shimizu T; Yokoe H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K J Cancer Res Clin Oncol; 2013 Apr; 139(4):585-94. PubMed ID: 23242234 [TBL] [Abstract][Full Text] [Related]
17. Kinesin family member 4A: a potential predictor for progression of human oral cancer. Minakawa Y; Kasamatsu A; Koike H; Higo M; Nakashima D; Kouzu Y; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K PLoS One; 2013; 8(12):e85951. PubMed ID: 24386490 [TBL] [Abstract][Full Text] [Related]
18. FBLIM1 enhances oral cancer malignancy via modulation of the epidermal growth factor receptor pathway. Toeda Y; Kasamatsu A; Koike K; Endo-Sakamoto Y; Fushimi K; Kasama H; Yamano Y; Shiiba M; Tanzawa H; Uzawa K Mol Carcinog; 2018 Dec; 57(12):1690-1697. PubMed ID: 30129678 [TBL] [Abstract][Full Text] [Related]
19. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system. Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844 [TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]